FIORINO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 968
AS - Asia 510
EU - Europa 152
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 52
SA - Sud America 24
OC - Oceania 1
Totale 1.764
Nazione #
US - Stati Uniti d'America 939
SG - Singapore 238
CN - Cina 168
IT - Italia 56
MA - Marocco 38
HK - Hong Kong 28
DE - Germania 26
GB - Regno Unito 18
BR - Brasile 15
CA - Canada 15
IN - India 12
PK - Pakistan 12
VN - Vietnam 12
FR - Francia 10
PL - Polonia 8
NL - Olanda 7
JP - Giappone 6
MX - Messico 6
UA - Ucraina 5
ZA - Sudafrica 5
BD - Bangladesh 4
IQ - Iraq 4
MY - Malesia 4
SE - Svezia 4
TR - Turchia 4
ES - Italia 3
ID - Indonesia 3
KE - Kenya 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BE - Belgio 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
AU - Australia 1
BF - Burkina Faso 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
GT - Guatemala 1
JM - Giamaica 1
KW - Kuwait 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.708
Città #
San Jose 179
Ashburn 162
Singapore 117
Dallas 100
The Dalles 42
Hefei 39
Casablanca 36
San Francisco 33
Council Bluffs 30
Hong Kong 27
Boardman 20
Munich 17
Seattle 17
New York 15
Santa Clara 15
Beijing 14
Las Vegas 13
Siena 12
Miami 10
Orem 10
Atlanta 9
Islamabad 9
Milan 9
Boston 8
Hillsboro 8
Los Angeles 8
Chicago 7
Warsaw 7
Florence 6
Phoenix 6
Tokyo 6
Manchester 5
Charlotte 4
Mexico City 4
Oxnard 4
Queens 4
Vyzhnytsya 4
Brooklyn 3
Buffalo 3
Chardon 3
Chengdu 3
Chennai 3
Hanoi 3
Johannesburg 3
Poplar 3
Princeton 3
Rome 3
Varese 3
Washington 3
Amman 2
Amsterdam 2
Ankara 2
Aveiro 2
Bari 2
Brandenburg 2
Brussels 2
Cairo 2
Calgary 2
Charleston 2
Columbus 2
Como 2
Frankfurt am Main 2
Guangzhou 2
Hayward 2
Ho Chi Minh City 2
Jacksonville 2
Kuala Lumpur 2
Limburg an der Lahn 2
Little Rock 2
Monroe 2
Montreal 2
Mumbai 2
Naples 2
New Delhi 2
North Charleston 2
Petaling Jaya 2
Providence 2
Quito 2
Rawalpindi 2
Reston 2
Shanghai 2
Shenzhen 2
Stockholm 2
Tegucigalpa 2
The Bronx 2
Winnipeg 2
Aarhus 1
Abakan 1
Abbeville 1
Abidjan 1
Alajuela 1
Albuquerque 1
Alexandria 1
Alpharetta 1
Anápolis 1
Araguari 1
Aryanah 1
Asunción 1
Augusta 1
Baghdad 1
Totale 1.140
Nome #
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 69
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 60
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 57
Immunization with the New Conjugate Vaccine against Salmonella Typhi Vi-CRM197 Induces Vi Specific Mucosal and Systemic Immune Responses in Mice 57
IFN-γ by NKs Enhances Bacterial Pathogenesis in a Murine Model of Meningitis by Type 4 Streptococcus 56
Vaginal immunization to elicit primary T-cell activation and dissemination 56
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 56
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 53
Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis 51
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 49
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 49
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort 49
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 49
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 48
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 48
Modulation of Primary Immune Response by Different Vaccine Adjuvants 47
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 46
Examining geospatial and temporal distribution of invasive non-typhoidalSalmonelladisease occurrence in sub-Saharan Africa: a systematic review and modelling study 46
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 45
Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis 44
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 43
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 43
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 43
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines 43
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 41
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 41
Prime-boost strategies in mucosal immunization affect local IgA production and the type of Th response 39
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. 36
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 35
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 34
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011 33
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 32
Are periodontitis and psoriasis associated? A pre‐clinical murine model 32
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 31
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 29
Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study 29
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 25
Primary T-cell response to mucosal vaccination 24
Machine learning approaches to dissect hybrid and vaccine-induced immunity 22
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 22
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 21
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 17
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 14
Totale 1.764
Categoria #
all - tutte 20.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 42 11 1 3 4 2
2023/2024208 5 38 11 22 35 33 16 2 4 13 8 21
2024/2025262 7 31 6 17 35 44 23 5 40 2 15 37
2025/20261.010 48 166 65 90 32 36 259 84 76 73 35 46
2026/2027221 17 26 59 119 0 0 0 0 0 0 0 0
Totale 1.764